DCF — LECONTE MEDICAL CENTER
Enterprise Value: $58.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$58.8M
Enterprise Value
$14.1M
PV of Cash Flows
$44.7M
PV of Terminal Value
$72.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $130.0M | $8.9M | 7.0% | $2.0M | $1.8M |
| Year 2 | $133.9M | $10.5M | 8.0% | $3.1M | $2.5M |
| Year 3 | $138.0M | $12.2M | 9.0% | $4.2M | $3.1M |
| Year 4 | $142.1M | $13.3M | 9.0% | $4.8M | $3.3M |
| Year 5 | $146.4M | $14.1M | 10.0% | $5.3M | $3.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $58.8M. Terminal value accounts for 76% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$126.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.06360078863760425
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5